Press Releases

BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth

  • Published on: November 24, 2021

…trusted partner to many top global pharmaceutical and biotech companies. For more information, visit embioagilytix.wpengine.com. About Cinven Cinven is a leading international private equityā€¦

Find Out More

BioAgilytix Closes Acquisition of Australia-based 360biolabsĀ®

  • Published on: October 13, 2021

…compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visitā€¦

Find Out More

BioAgilytix Announces New Partnership With CTI

  • Published on: October 4, 2021

…a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit embioagilytix.wpengine.com. About CTI CTI Clinical Trial and Consulting Servicesā€¦

Find Out More

For the 8th Time, BioAgilytix Named to Inc. 5000 Annual List of Americaā€™s Fastest-Growing Private Companies

  • Published on: August 26, 2021

…science, data integrity and regulatory compliance through all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotechā€¦

Find Out More

MicroConstants to Join BioAgilytix Family

  • Published on: August 18, 2021

…global pharmaceutical and biotech companies. For more information, visit embioagilytix.wpengine.com. About MicroConstants, Inc. MicroConstants Inc., is one of the largest bioanalytical LC/MS service providersā€¦

Find Out More

BioAgilytix to Purchase Australia-based 360biolabsĀ®

  • Published on: August 16, 2021

…development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit embioagilytix.wpengine.com. About 360biolabs® 360biolabs® is theā€¦

Find Out More

BioAgilytix Welcomes Amanda L. Hays, Ph.D. To Team As Scientific Officer

  • Published on: July 12, 2021

…all phases of clinical development. BioAgilytix is a trusted partner to many top global pharmaceutical and biotech companies. For more information, visit embioagilytix.wpengine.com. Media Contact:ā€¦

Find Out More

BioAgilytix Holds Ribbon Cutting to Celebrate Boston Lab Expansion, Additional Jobs and Tech Capabilities

  • Published on: June 8, 2021

…global pharmaceutical and biotech companies. For more information, visit embioagilytix.wpengine.com. Media Contact: Jennifer Absher BioAgilytix (919) 744-7884 media@bioagilytix.com BOSTON, Massachusetts – BioAgilytix, a leadingā€¦

Find Out More

BioAgilytix Is Re-approved and Registered For The French Research Tax Credit (CIR)

  • Published on: January 13, 2021

HAMBURG, GERMANY: Jan 13, 2021 – BioAgilytix is thrilled to announce that our European lab in Hamburg, Germany is now CIR approved for 2020, 2021ā€¦

Find Out More

BioAgilytix Bioanalytical Lab Welcomes the Phadia 200 to Its Hamburg Laboratory

  • Published on: October 30, 2020

HAMBURG, Germany — BioAgilytix is thrilled to announce the addition of a new diagnostics tool to their growing list of cutting-edge bioanalysis instruments. With theā€¦

Find Out More